1. Home
  2. RCUS vs WAY Comparison

RCUS vs WAY Comparison

Compare RCUS & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$27.85

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo Waystar Holding Corp.

WAY

Waystar Holding Corp.

HOLD

Current Price

$22.68

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
WAY
Founded
2015
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.8B
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
RCUS
WAY
Price
$27.85
$22.68
Analyst Decision
Buy
Strong Buy
Analyst Count
10
17
Target Price
$31.90
$36.59
AVG Volume (30 Days)
1.5M
3.0M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
569.23
EPS
N/A
0.22
Revenue
$247,000,000.00
$1,099,278,000.00
Revenue This Year
N/A
$18.26
Revenue Next Year
$45.62
$10.62
P/E Ratio
N/A
$100.64
Revenue Growth
N/A
16.50
52 Week Low
$8.84
$17.26
52 Week High
$31.74
$39.99

Technical Indicators

Market Signals
Indicator
RCUS
WAY
Relative Strength Index (RSI) 50.80 58.31
Support Level $19.78 $21.03
Resistance Level $28.72 $26.73
Average True Range (ATR) 1.49 0.98
MACD -0.34 0.18
Stochastic Oscillator 16.46 64.84

Price Performance

Historical Comparison
RCUS
WAY

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

About WAY Waystar Holding Corp.

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: